Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 14.

Journal Article

Becker, H. J., Reuter, S., Marquez, Garcia M., Schloesser, H. A., von Bergwelt-Baildon, M. and Theurich, S. (2016). B cells derived from patients with von Hippel-Lindau (VHL) disease display impaired antigen presentation upon CD40 activation. Oncol. Res. Treat., 39. S. 271 - 272. BASEL: KARGER. ISSN 2296-5262

Dieplinger, G., Mokhaberi, N., Wahba, R., Peltzer, S., Buchner, D., Schloesser, H. A., Ditt, V, von Borstel, A., Bauerfeind, U., Lange, U., Arns, W., Kurschat, C., Stippel, H. A. and Vitinius, F. (2018). Correlation Between the Transplant Evaluation Rating Scale (TERS) and Medical Outcomes in Living-Donor Kidney Transplant Recipients: A Retrospective Analysis. Transplant. Proc., 50 (5). S. 1276 - 1281. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1873-2623

Fischer, R. N., Scheel, A. H., Rothschild, S., I, Schloesser, H. A., Wolf, J., Buettner, R., Ansen, S. and von Bergwelt-Baildon, M. (2015). Tumor-infiltrating B lymphocytes characterized by CD79a and MUM1 independently predict outcome in patients with non-small cell lung cancer. Oncol. Res. Treat., 38. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262

Garcia-Marquez, M. A., Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Gathof, B., Maas, L., George, J., Bruns, C., Quaas, A., von Bergwelt-Baildon, M., Peifer, M. and Schloesser, H. A. (2021). GENOMIC HLA HOMOZYGOSITY IS FREQUENT IN ESOPHAGEAL ADENOCARCINOMA AND RELATED TO LOW IMMUNOGENICITY. J. Immunother. Cancer, 9. S. A1 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Marquez, Ma Garcia, Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Maas, L., Nicolik, M., George, J., Zander, T., Schroeder, W., Mueller, P., Bruns, C., Thomas, R., Gathof, B., Quaas, A., Hillmer, A. M., Peifer, M., von Bergwelt-Baildon, M. and Schloesser, H. A. (2022). HEREDITARY HOMOZYGOSITY AND ALLELIC IMBALANCE OF HLA AS COMMON IMMUNE ESCAPE MECHANISMS IN ESOPHAGEAL ADENOCARCINOMA. J. Immunother. Cancer, 10. S. A38 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Mellinghoff, S. C., Banck, J. C., Mueller, N., Thelen, M., Schloesser, H. A., Cornely, O. A. and von Bergwelt-Baildon, M. (2020). Immune checkpoint blockade for aspergillosis and mucormycosis co-infection. Mycoses, 63. S. 24 - 25. HOBOKEN: WILEY. ISSN 1439-0507

Preugszat, E., Thelen, M., Garcia-Marquez, M., Lehmann, J., Keller, D., von Bergwelt-Baildon, M. and Schloesser, H. A. (2021). CANCER-SPECIFIC DIFFERENCES OF TERTIARY LYMPHOID STRUCTURES AND CELLULAR RESPONSES AGAINST FREQUENTLY EXPRESSED CANCER TESTIS ANTIGENS. J. Immunother. Cancer, 9. S. A19 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Schloesser, H. A., Shimabukuro-Vornhagen, A., Scherwitz, P., Koslowsky, T., Eidt, S., Stippel, D. L. and von Bergwelt-Baildon, M. S. (2014). Characterization of tumor associated b cells in colorectal cancer. Oncol. Res. Treat., 37. S. 45 - 46. BASEL: KARGER. ISSN 2296-5262

Schloesser, H. A., Thelen, M., Dieplinger, G., von Bergwelt-Baildon, A., Heiermann, N., Kleinert, R., Wahba, R., Ditt, V., Kurschat, C., Cingoez, T., Becker, J., Stippel, D. and von Bergwelt-Baildon, M. (2016). PROSPECTIVE ANALYSES OF CIRCULATING B-CELL SUBSETS IN ABO-COMPATIBLE AND ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS. Transpl. Int., 29. S. 44 - 45. HOBOKEN: WILEY-BLACKWELL. ISSN 1432-2277

Schloesser, H. A., Thelen, M., Lechner, A., Gilles, R., Garcia-Marquez, M., Wennhold, K., Alakus, H., Schroeder, W., Moenig, S., Theurich, S., Shimabukuro-Vornhagen, A., Gathof, B., Drebber, U., Quaas, A., Bruns, C., Hoelscher, A. H. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in esophago-gastric adenocarcinoma. Oncol. Res. Treat., 40. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262

Thelen, M., Garcia-Marquez, M., Lehmann, J., Keller, D., Preugszat, E., von Bergwelt-Baildon, M. and Schloesser, H. A. (2021). ENDOGENOUS T-CELL RESPONSES TO TEN MAJOR CANCER TESTIS ANTIGENS ARE FREQUENT IN ESOPHAGO-GASTRIC ADENOCARCINOMA AND ANTIGEN-SPECIFIC T CELLS CAN BE EXPANDED USING CD40-ACTIVATED B CELLS. J. Immunother. Cancer, 9. S. A21 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Thelen, M., Keller, D., Lehmann, J., Wennhold, K., Weitz, H., Bauer, E., Gathof, B., Brueggemann, M., Kotrova, M., Quaas, A., Mallmann, C., Chon, S., Hillmer, A. M., Bruns, C., von Bergwelt-Baildon, M., Garcia-Marquez, M. A. and Schloesser, H. A. (2022). IMMUNE RESPONSES AGAINST SHARED ANTIGENS ARE COMMON IN ESOPHAGO-GASTRIC CANCER AND CAN BE ENHANCED USING CD40-ACTIVATED B CELLS. J. Immunother. Cancer, 10. S. A24 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Theurich, S., Becker, H. J., Malcher, J., Marquez, M. G., Wennhold, K., Reuter, S., Shimabukuro-Vornhagen, A., Schloesser, H. A., Huelsemann, M., Frenzel, L. P. and von Bergwelt-Baildon, M. (2017). Hypoxia and iron-chelation decrease antigen-presenting functions in CD40-activated human B cells. Oncol. Res. Treat., 40. S. 255 - 256. BASEL: KARGER. ISSN 2296-5262

Wahba, R., Vitinius, F., Dieplinger, G., Kleinert, R., Buchner, D., Heiermann, N., Walczuch, B., Datta, R., Schloesser, H. A., Hellmich, M., Kurschat, C. and Stippel, D. L. (2018). INFLUENCE OF HAND-ASSISTED RETROPERITONEOSCOPIC DONOR NEPHRECTOMY (HARP) ON HEALTH-RELATED QUALITY OF LIFE AFTER LIVING DONATION - FIRST RESULTS OF THE QOLID-STUDY. Transpl. Int., 31. S. 42 - 43. HOBOKEN: WILEY. ISSN 1432-2277

This list was generated on Thu Mar 28 18:55:10 2024 CET.